Aspiriant, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
Ava Hoppe | 28 July, 2023
In today's blog post, we will be discussing the changes in holdings of Aspiriant, LLC's Q1 2023 and Q2 2023 filings. We will explore the key highlights and analyze the shifts in their portfolio.
As a quick background, 13F filings are reports required by the Securities and Exchange Commission (SEC) that provide information on the holdings of institutional investment managers with assets under management greater than $100 million. These filings offer valuable insights into the investments made by these firms and help investors track their activities.
Now, let's dive into the data and examine the significant changes in Aspiriant, LLC's portfolio.
ACWV - iShares Inc:
- Q1 2023 (SHARES): 2,839,032
- Q2 2023 (SHARES): 2,801,934
- Q1 2023 VALUE ($000): 274,676
- Q2 2023 VALUE ($000): 274,743
- Chg %: 0
VTEB - Vanguard Mun Bd Fds:
- Q1 2023 (SHARES): 4,016,961
- Q2 2023 (SHARES): 3,945,736
- Q1 2023 VALUE ($000): 203,499
- Q2 2023 VALUE ($000): 198,154
- Chg %: -2.6
IUSV - iShares TR:
- Q1 2023 (SHARES): 2,304,801
- Q2 2023 (SHARES): 2,282,871
- Q1 2023 VALUE ($000): 170,048
- Q2 2023 VALUE ($000): 178,657
- Chg %: 5.1
VIG - Vanguard Specialized Funds:
- Q1 2023 (SHARES): 955,883
- Q2 2023 (SHARES): 951,102
- Q1 2023 VALUE ($000): 147,215
- Q2 2023 VALUE ($000): 154,486
- Chg %: 4.9
VBR - Vanguard Index Fds:
- Q1 2023 (SHARES): 723,560
- Q2 2023 (SHARES): 723,574
- Q1 2023 VALUE ($000): 114,871
- Q2 2023 VALUE ($000): 119,679
- Chg %: 4.2
EFV - iShares TR:
- Q1 2023 (SHARES): 1,292,616
- Q2 2023 (SHARES): 1,280,269
- Q1 2023 VALUE ($000): 62,730
- Q2 2023 VALUE ($000): 62,656
- Chg %: -0.1
VOO - Vanguard Index Fds:
- Q1 2023 (SHARES): 151,437
- Q2 2023 (SHARES): 149,837
- Q1 2023 VALUE ($000): 56,949
- Q2 2023 VALUE ($000): 61,023
- Chg %: 7.2
IEMG - iShares Inc:
- Q1 2023 (SHARES): 1,111,221
- Q2 2023 (SHARES): 1,116,985
- Q1 2023 VALUE ($000): 54,216
- Q2 2023 VALUE ($000): 55,056
- Chg %: 1.5
AAPL - Apple Inc:
- Q1 2023 (SHARES): 285,728
- Q2 2023 (SHARES): 275,658
- Q1 2023 VALUE ($000): 47,116
- Q2 2023 VALUE ($000): 53,469
- Chg %: 13.5
IVV - iShares TR:
- Q1 2023 (SHARES): 106,545
- Q2 2023 (SHARES): 117,863
- Q1 2023 VALUE ($000): 43,798
- Q2 2023 VALUE ($000): 52,532
- Chg %: 19.9
These are just a few of the holdings that have experienced changes in Aspiriant, LLC's portfolio. It's important to note that these changes could be influenced by various factors such as market conditions, investment strategies, and market outlook. Therefore, investors should closely study the full 13F filing for a comprehensive understanding of Aspiriant, LLC's investment decisions.
Please remember that this article is for informational purposes only and should not be considered as financial advice. It's always recommended to consult with a qualified financial advisor before making any investment decisions.
In conclusion, the Q1 2023 vs. Q2 2023 13F holdings comparison of Aspiriant, LLC reveals interesting shifts in their investment portfolio. Investors in the financial markets can use this information as a starting point for further analysis and exploration of potential investment opportunities. Stay tuned for more updates and analysis on the ever-evolving world of investments!
Other Posts
- Nordson Corporation Set to Boost Crop Yields with ARAG Acquisition: A Market and Technology Leader in Precision Spraying Solutions
- Harbor Island Capital LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Analyzing F3Logic LLC's Q4 2022 Holdings: A Look at Changes in Investment Strategies and Potential Market Trends.
- Navigating the Infrastructure Investment Labyrinth: A Guide to Antin's 2023 Universal Registration Document
- **Title:** The Successful Exit of New Heritage Capital: Revela Foods Acquired by ADM
- IFP Advisors, Inc Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Carlson Capital Management's Q4 2022 vs. Q1 2023 13F Holdings Comparison Shows Increase in Most Stocks
- The Rise and Fall of Real Estate Investments: Q1 2020 vs. Q2 2020 Holdings Comparison by Security Capital Research & Management Inc
- Calamos Wealth Management's Q3 2022 vs. Q4 2022 13F Holdings: Which Stocks Rose and Which Fell?
- Investment Firm Three Peaks Capital Management Reports Q2 vs. Q3 2021 Holdings